Cochlear LtdCOH:ASX

0.40 / 0.63%
Latest price in AUDToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Jul 31 2014 06:02 BST.

Income statement in AUD

Year on year Cochlear Ltd had revenues fall 3.37% from 778.9960m to 752.7210m, though the company grew net income 133.37% from 56.8030m to 132.5630m. View full income statement

Gross margin69.01%
Net profit margin10.37%
Operating margin13.31%
Return on assets9.77%
Return on equity21.29%
Return on investment13.70%

Growth rates in AUD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 2.86% and 132.86%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.

Div yield(5 year avg)3.33%
Div growth rate (5 year)10.93%
Payout ratio (TTM)190.82%
EPS growth(5 years)2.38
EPS (TTM) vs
TTM 1 year ago

Cash flow in AUD

In 2013, cash reserves at Cochlear Ltd fell by 15.7970m. However, the company earned 69.7270m from its operations for a Cash Flow Margin of 9.26%. In addition the company used 50.4190m on investing activities and also paid 38.8590m in financing cash flows. View full cash flow statement

Cash flow per share--
Price/Cash flow per share--
Book value per share5.66
Tangible book value per share1.29

Balance sheet in AUD

Cochlear Ltd has a Debt to Total Capital ratio of 41.24%, a higher figure than the previous year's 16.35%. View full balance sheet

Current ratio2.19
Quick ratio1.47
Total debt/total equity0.7019
Total debt/total capital0.4124
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.